Reliability of a New Pulse Contour Technique for Diagnosing an Increase in Stroke Volume During a Fluid Challenge for Hemodynamic Optimization in Patients Scheduled for High-risk Abdominal Surgery: Comparison With Transthoracic Echocardiography: COMPARE Study
COMPARE
1 other identifier
observational
100
1 country
1
Brief Summary
The present study aims at assessing the ability of a new pulse contour device for diagnosing a \>15% stroke volume (SV) increase during patient hemodynamic optimization by fluid challenge in high risk abdominal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2016
CompletedFirst Submitted
Initial submission to the registry
April 29, 2021
CompletedFirst Posted
Study publicly available on registry
May 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 8, 2024
CompletedJune 18, 2026
June 1, 2026
7.7 years
April 29, 2021
June 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ability of pulse contour for diagnosing a >15% increase in stroke volume
Ability of pulse contour for diagnosing a \>15% increase in stroke volume
15 minutes
Secondary Outcomes (2)
Comparison with the ability of other techniques
15 minutes
Ability for predicting a >15% SV increase
15 minutes
Study Arms (1)
Hemodynamic optimization
Patients scheduled for intermediate and high-risk abdominal surgery were eligible to participate
Interventions
The stroke volume will be measured before and after 15 minutes fluid challenge with crystalloids
Eligibility Criteria
Patients scheduled for intermediate and high-risk abdominal surgery were eligible to participate
You may qualify if:
- Adult patient ASA status 1-3 who were orally informed and did refuse to participate.
- Patient in whom general anesthesia with tracheal intubation were planned.
- Patient in whom an arterial catheter and a monitoring of cardiac output by esophageal Doppler were indicated for hemodynamic optimization
- Patient with cardiac sinusal mode
You may not qualify if:
- Patient \< 18-year-old
- Cardiac arrythmia
- Patient with anomaly in oro-pharyngo-esophageal tractus
- Patients with hemostasis anomaly (PT \< 30%, platelets \< 50 000 elements/mm3)
- Patient in whom the cardiac output monitoring or measurement was not possible by Esophageal Doppler or echography
- Patients in whom cardiac arrythmia occurred during the procedure of hemodynamic optimization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de NIMES
Nîmes, 30029, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2021
First Posted
May 4, 2021
Study Start
April 12, 2016
Primary Completion
January 8, 2024
Study Completion
January 8, 2024
Last Updated
June 18, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share